Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Physical Activity as a Risk Factor for Cancer in Chinese Participants
This study is currently recruiting participants.
Verified by National Cancer Institute (NCI), April 2008
First Received: June 19, 2006   Last Updated: February 6, 2009   History of Changes
Sponsored by: National Cancer Institute (NCI)
Information provided by: National Cancer Institute (NCI)
ClinicalTrials.gov Identifier: NCT00340067
  Purpose

RATIONALE: The amount and type of physical activity in a person's life may affect the risk of developing cancer. Learning about the long-term effects of physical activity on cancer risk may help the study of cancer in the future.

PURPOSE: This clinical trial is studying physical activity as a risk factor for cancer in Chinese participants.


Condition Intervention
Health Status Unknown
Other: laboratory biomarker analysis
Other: questionnaire administration
Procedure: study of high risk factors

MedlinePlus related topics: Cancer
U.S. FDA Resources
Study Type: Observational
Official Title: Physical Activity and Its Components in Relation to Plasma Inflammatory Markers of Cancer Risk Among Chinese Adults

Further study details as provided by National Cancer Institute (NCI):

Primary Outcome Measures:
  • Development of a comprehensive, reliable physical activity questionnaire
  • Validation of the physical activity questionnaire using the accelerometer as an objective measure of physical activity
  • Correlation of different types and parameters of physical activity with plasma inflammatory biomarkers of cancer risk

Estimated Enrollment: 600
Study Start Date: July 2005
Detailed Description:

OBJECTIVES:

  • Develop a comprehensive physical activity questionnaire that includes standardized questions about all types of physical activity (e.g., recreational, household, occupational, and transportation-related), as well as parameters of physical activity (e.g., frequency, intensity, and duration in hours per week).
  • Assess the validity and reliability of this comprehensive physical activity questionnaire using an accelerometer to objectively measure physical activity.
  • Determine whether different types and parameters of physical activity are associated with circulating levels of specific inflammatory biomarkers that have been linked to cancer risk (i.e., C-reactive protein, interleukin 6, and soluble tumor necrosis factor alpha).

OUTLINE: This is a prospective study.

Participants complete a self-administered physical activity questionnaire at baseline to measure their level of physical activity. Participants complete additional activity questionnaires during 30-35 minute interviews conducted at the beginning of the study and at approximately 12 months. Physical activity levels are assessed every 3 months during study using a participant-reported physical activity diary and an activity monitor that is worn at the waist to record participants' physical activity patterns over a 7-day period. Participants also complete a 7-day recall of their physical activities during this period.

Blood and urine samples are collected periodically during study to evaluate levels of nutrients and certain proteins, including specific plasma inflammatory markers that have been linked to cancer risk (i.e., C-reactive protein, interleukin 6, and soluble tumor necrosis factor alpha). The samples are stored for future studies related to nutrition and physical activity, as well as possible research on gene variation and its relationship to health, nutrition, exercise, or disease.

  Eligibility

Ages Eligible for Study:   40 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

DISEASE CHARACTERISTICS:

  • Concurrently participating in the "Protect Health and Reduce Cancer Risk" study in either of the following cohorts:

    • Shanghai Women's Cohort
    • Shanghai Men's Cohort

PATIENT CHARACTERISTICS:

  • No physical ailments that would preclude study participation

PRIOR CONCURRENT THERAPY:

  • Not specified
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00340067

Locations
China
Shanghai Cancer Institute Recruiting
Shanghai, China, 200032
Contact: Xiang Yong-Bing, MD, MPH     86-21-6404-7029        
Sponsors and Collaborators
Investigators
Principal Investigator: Michael Leitzmann, MD, PhD National Cancer Institute (NCI)
  More Information

Additional Information:
No publications provided

Study ID Numbers: CDR0000555128, NCI-05-C-N190
Study First Received: June 19, 2006
Last Updated: February 6, 2009
ClinicalTrials.gov Identifier: NCT00340067     History of Changes
Health Authority: Unspecified

Keywords provided by National Cancer Institute (NCI):
health status unknown

ClinicalTrials.gov processed this record on May 07, 2009